Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0421 | 0.1726 | 0.1726 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0448 | 0.1945 | 0.8658 |
Brugia malayi | Cyclin, N-terminal domain containing protein | 0.0313 | 0.0857 | 0.0857 |
Giardia lamblia | Kinase, CMGC CDK | 0.0393 | 0.1501 | 0.7415 |
Echinococcus granulosus | cyclins | 0.0313 | 0.0857 | 0.3815 |
Echinococcus multilocularis | cyclin dependent kinase | 0.0393 | 0.1501 | 0.6685 |
Leishmania major | CYC2-like cyclin, putative,cyclin 6, putative | 0.0421 | 0.1726 | 1 |
Schistosoma mansoni | cyclin-dependent kinase 5 activator | 0.0287 | 0.0648 | 0.2883 |
Onchocerca volvulus | 0.0421 | 0.1726 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.0379 | 0.1387 | 0.1387 |
Trichomonas vaginalis | cyclin B, putative | 0.0421 | 0.1726 | 1 |
Trichomonas vaginalis | cyclins, putative | 0.0421 | 0.1726 | 1 |
Schistosoma mansoni | g1/s-specific cyclin C | 0.0485 | 0.2246 | 1 |
Echinococcus granulosus | cyclin dependent kinase 7 | 0.0448 | 0.1945 | 0.8658 |
Toxoplasma gondii | cell-cycle-associated protein kinase CDK, putative | 0.0393 | 0.1501 | 1 |
Echinococcus multilocularis | G2:mitotic specific cyclin B3 | 0.0313 | 0.0857 | 0.3815 |
Loa Loa (eye worm) | CMGC/CDK/CDC2 protein kinase | 0.0393 | 0.1501 | 0.1501 |
Trichomonas vaginalis | cyclins, putative | 0.0313 | 0.0857 | 0.496 |
Brugia malayi | cell division control protein 2 homolog | 0.0393 | 0.1501 | 0.1501 |
Echinococcus multilocularis | cyclin dependent kinase 7 | 0.0448 | 0.1945 | 0.8658 |
Schistosoma mansoni | cyclins | 0.0313 | 0.0857 | 0.3815 |
Loa Loa (eye worm) | cyclin domain-containing protein | 0.0313 | 0.0857 | 0.0857 |
Echinococcus multilocularis | cyclins | 0.0313 | 0.0857 | 0.3815 |
Plasmodium vivax | protein kinase Crk2 | 0.0393 | 0.1501 | 0.5 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0393 | 0.1501 | 0.8697 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0393 | 0.1501 | 0.6685 |
Leishmania major | cyclin | 0.0421 | 0.1726 | 1 |
Echinococcus multilocularis | cyclin b3 | 0.0313 | 0.0857 | 0.3815 |
Trypanosoma cruzi | cyclin, putative | 0.0421 | 0.1726 | 1 |
Trichomonas vaginalis | cyclin A, putative | 0.0421 | 0.1726 | 1 |
Entamoeba histolytica | cyclin, putative | 0.0313 | 0.0857 | 0.4817 |
Echinococcus multilocularis | cyclins | 0.0313 | 0.0857 | 0.3815 |
Loa Loa (eye worm) | CMGC/CDK/CDK5 protein kinase | 0.0393 | 0.1501 | 0.1501 |
Schistosoma mansoni | cyclin B3 | 0.0313 | 0.0857 | 0.3815 |
Echinococcus granulosus | cyclin dependent kinase 9 | 0.0241 | 0.0277 | 0.1233 |
Echinococcus granulosus | cyclins | 0.0313 | 0.0857 | 0.3815 |
Echinococcus granulosus | cyclin dependent kinase | 0.0393 | 0.1501 | 0.6685 |
Loa Loa (eye worm) | hypothetical protein | 0.0381 | 0.1409 | 0.1409 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0448 | 0.1945 | 0.8658 |
Brugia malayi | Cyclin, N-terminal domain containing protein | 0.0421 | 0.1726 | 0.1726 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0393 | 0.1501 | 0.8697 |
Plasmodium falciparum | protein kinase 5 | 0.0393 | 0.1501 | 1 |
Echinococcus granulosus | cyclin B3 1 | 0.0313 | 0.0857 | 0.3815 |
Trichomonas vaginalis | cyclin B3, putative | 0.0313 | 0.0857 | 0.496 |
Trichomonas vaginalis | cyclins, putative | 0.0421 | 0.1726 | 1 |
Loa Loa (eye worm) | cyclin C | 0.0485 | 0.2246 | 0.2246 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0313 | 0.0857 | 0.496 |
Trypanosoma cruzi | cyclin 6, putative | 0.0421 | 0.1726 | 1 |
Echinococcus multilocularis | cyclin dependent kinase 1 | 0.0393 | 0.1501 | 0.6685 |
Loa Loa (eye worm) | cyclin domain-containing protein | 0.1445 | 1 | 1 |
Echinococcus granulosus | 5'partial|cyclin dependent kinase 1 | 0.0393 | 0.1501 | 0.6685 |
Echinococcus granulosus | cyclin b3 | 0.0313 | 0.0857 | 0.3815 |
Echinococcus multilocularis | cyclins | 0.0313 | 0.0857 | 0.3815 |
Trichomonas vaginalis | cyclin B, putative | 0.0421 | 0.1726 | 1 |
Echinococcus multilocularis | cyclins | 0.0313 | 0.0857 | 0.3815 |
Echinococcus multilocularis | oligomeric golgi complex subunit 3 | 0.0485 | 0.2246 | 1 |
Echinococcus granulosus | cyclins | 0.0313 | 0.0857 | 0.3815 |
Schistosoma mansoni | cyclin B | 0.0421 | 0.1726 | 0.7686 |
Entamoeba histolytica | cyclin family protein | 0.0313 | 0.0857 | 0.4817 |
Entamoeba histolytica | hypothetical protein | 0.0361 | 0.1245 | 0.7 |
Echinococcus multilocularis | cyclin dependent kinase 5 | 0.0393 | 0.1501 | 0.6685 |
Echinococcus granulosus | cyclin | 0.0485 | 0.2246 | 1 |
Trichomonas vaginalis | cyclins, putative | 0.0421 | 0.1726 | 1 |
Echinococcus multilocularis | cyclins | 0.0313 | 0.0857 | 0.3815 |
Loa Loa (eye worm) | cyclin domain-containing protein | 0.0846 | 0.5163 | 0.5163 |
Trichomonas vaginalis | cyclin B, putative | 0.0313 | 0.0857 | 0.496 |
Echinococcus granulosus | cyclin dependent kinase 5 activator 1 | 0.0287 | 0.0648 | 0.2883 |
Echinococcus multilocularis | cyclin dependent kinase 1 | 0.0393 | 0.1501 | 0.6685 |
Trichomonas vaginalis | cyclin D, putative | 0.0313 | 0.0857 | 0.496 |
Echinococcus granulosus | cyclin B | 0.0421 | 0.1726 | 0.7686 |
Brugia malayi | Cyclin C | 0.0485 | 0.2246 | 0.2246 |
Echinococcus granulosus | oligomeric golgi complex subunit 3 | 0.0485 | 0.2246 | 1 |
Echinococcus granulosus | cyclins | 0.0313 | 0.0857 | 0.3815 |
Loa Loa (eye worm) | hypothetical protein | 0.0287 | 0.0648 | 0.0648 |
Brugia malayi | Protein kinase domain containing protein | 0.0393 | 0.1501 | 0.1501 |
Echinococcus multilocularis | cyclin dependent kinase 5 activator 1 | 0.0287 | 0.0648 | 0.2883 |
Echinococcus multilocularis | cyclin B | 0.0421 | 0.1726 | 0.7686 |
Echinococcus multilocularis | cyclins | 0.0313 | 0.0857 | 0.3815 |
Entamoeba histolytica | cell division protein kinase 2, putative | 0.0427 | 0.1778 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0421 | 0.1726 | 0.1726 |
Echinococcus granulosus | cyclin dependent kinase 1 | 0.0393 | 0.1501 | 0.6685 |
Giardia lamblia | G2/mitotic-specific cyclin B | 0.0421 | 0.1726 | 1 |
Trichomonas vaginalis | cyclin B, putative | 0.0421 | 0.1726 | 1 |
Echinococcus multilocularis | cyclins | 0.0313 | 0.0857 | 0.3815 |
Trichomonas vaginalis | cyclin H, putative | 0.0361 | 0.1245 | 0.721 |
Entamoeba histolytica | cell division protein kinase 2, putative | 0.0393 | 0.1501 | 0.8442 |
Entamoeba histolytica | cyclin family protein | 0.0313 | 0.0857 | 0.4817 |
Trichomonas vaginalis | cyclins, putative | 0.0421 | 0.1726 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0393 | 0.1501 | 0.8697 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0393 | 0.1501 | 0.6685 |
Trichomonas vaginalis | cyclin D, putative | 0.0313 | 0.0857 | 0.496 |
Trichomonas vaginalis | cyclin B, putative | 0.0421 | 0.1726 | 1 |
Echinococcus multilocularis | cyclin | 0.0485 | 0.2246 | 1 |
Echinococcus granulosus | cyclins | 0.0313 | 0.0857 | 0.3815 |
Loa Loa (eye worm) | CMGC/CDK/CDK7 protein kinase | 0.0448 | 0.1945 | 0.1945 |
Trypanosoma cruzi | CYC2-like cyclin, putative | 0.0421 | 0.1726 | 1 |
Trypanosoma brucei | mitotic cyclin 6 | 0.0421 | 0.1726 | 1 |
Echinococcus multilocularis | cyclin dependent kinase 9 | 0.0241 | 0.0277 | 0.1233 |
Loa Loa (eye worm) | CMGC/CDK/CDC2 protein kinase | 0.0393 | 0.1501 | 0.1501 |
Brugia malayi | Cyclin, N-terminal domain containing protein | 0.0846 | 0.5163 | 0.5163 |
Giardia lamblia | Kinase, CMGC CDK | 0.0393 | 0.1501 | 0.7415 |
Echinococcus granulosus | cyclin dependent kinase 5 | 0.0393 | 0.1501 | 0.6685 |
Trypanosoma cruzi | cyclin, putative | 0.0421 | 0.1726 | 1 |
Echinococcus multilocularis | cyclin B3 1 | 0.0313 | 0.0857 | 0.3815 |
Brugia malayi | cyclin-dependent kinase 7 homolog | 0.0482 | 0.2222 | 0.2222 |
Entamoeba histolytica | cyclin, putative | 0.0421 | 0.1726 | 0.9706 |
Echinococcus granulosus | G2:mitotic specific cyclin B3 | 0.0313 | 0.0857 | 0.3815 |
Brugia malayi | Cyclin, N-terminal domain containing protein | 0.0421 | 0.1726 | 0.1726 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.